Cited by 111T-cell and B-cell ImmunologyPsoriasis: Treatment and PathogenesisImmunotherapy and Immune Responses

Local heroes or villains: tissue-resident memory T cells in human health and disease

Open access
Sasson, S. C., Gordon, C. L., Christo, S. N., Klenerman, P., Mackay, L. K.·2020·Cellular & Molecular Immunology

Abstract

Tissue-resident memory T (T RM) cells are increasingly associated with the outcomes of health and disease. T RM cells can mediate local immune protection against infections and cancer, which has led to interest in T RM cells as targets for vaccination and immunotherapies. However, these cells have also been implicated in mediating detrimental pro-inflammatory responses in autoimmune skin diseases such as psoriasis, alopecia areata, and vitiligo. Here, we summarize the biology of T RM cells established in animal models and in translational human studies. We review the beneficial effects of T RM cells in mediating protective responses against infection and cancer and the adverse role of T RM cells in driving pathology in autoimmunity. A further understanding of the breadth and mechanisms of T RM cell activity is essential for the safe design of strategies that manipulate T RM cells, such that protective responses can be enhanced without unwanted tissue damage, and pathogenic T RM cells can be eliminated without losing local immunity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41423-019-0359-1

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In organs other than the heart, TRM cells have been incriminated as key drivers of autoimmune diseases including psoriasis, vitiligo, type 1 diabetes, idiopathic arthritis, Alzheimer disease, and multiple sclerosis.

    “Moreover, in other organs than the heart, T RM cells have been incriminated as key drivers of autoimmune diseases including psoriasis, vitiligo, type 1 diabetes, idiopathic arthritis, Alzheimer disease, and multiple sclerosis. 294,302-310”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [294]

    The 'T RM CELLS IN AUTOIMMUNITY' section implicates tissue-resident memory T cells in multiple sclerosis and type 1 diabetes, and the skin-disease sections discuss their possible pathogenic roles in psoriasis and vitiligo. The source does not establish that they are key drivers of all these diseases: it says their direct contribution to psoriasis exacerbation is unknown. Our copy also does not address idiopathic arthritis or Alzheimer disease. Page numbers were not available in the supplied passages. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • TRM cells can be distinguished from effector memory T cells by downregulation of S1PR1 and upregulation of tissue retention molecules like CD103 and CD69.

    “T RM cells can be distinguished from effector memory T cells by their downregulation of tissue egress protein S1PR1 (sphingosine 1-phosphate receptor) and upregulation of tissue retention molecules like CD103 and CD69. 292-294”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [294]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 34

  1. Collins, N. et al. Skin CD4(+) memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation. Nat. Commun. 7, 11514 (2016).
  2. Teijaro, J. et al. Cutting edge: tissue-retentive lung memory CD4 T cells mediate optimal protection to respiratory virus infection. J. Immunol. 187, 5510 (2011).
  3. Pallett, L. et al. IL-2(high) tissue-resident T cells in the human liver: sentinels for hepatotropic infection. J. Exp. Med. 214, 1567 (2017).
  4. Kumar, B. V. et al. Functional heterogeneity of human tissue-resident memory T cells based on dye efflux capacities. JCI Insight 3, e123568 (2018).
  5. Thom, J., Weber, T., Walton, S., Torti, N. & Oxenius, A. The salivary gland acts as a sink for tissue-resident memory CD8+ T cells, facilitating protection from local cytomegalovirus infection. Cell Rep. 13, 1125 (2015).
  6. Zaid, A. et al. Persistence of skin-resident memory T cells within an epidermal niche. Proc. Natl Acad. Sci. USA 111, 5307-5312 (2014).
  7. Schenkel, J., Fraser, K. A., Vezys, V. & Masopust, D. Sensing and alarm function of resident memory CD8+ T cells. Nat. Immunol. 14, 509 (2013).
  8. Mackay, L. et al. Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation. Proc. Natl Acad. Sci. USA 109, 7037-7042 (2012).
  9. Shin, H. & Iwasaki, A. A vaccine strategy that protects against genital herpes by establishing local memory T cells. Nature 491, 463 (2012).
  10. Liu, L. et al. Epidermal injury and infection during poxvirus immunization is crucial for the generation of highly protective T cell-mediated immunity. Nat. Med. 16, 224 (2010).
  11. Bartolomé-Casado, R. et al. Resident memory CD8 T cells persist for years in human small intestine. J. Exp. Med. https://doi.org/10.1084/jem.20190414 (2019). · DOI
  12. Hofmann, M. & Pircher, H. E-cadherin promotes accumulation of a unique memory CD8 T-cell population in murine salivary glands. Proc. Natl Acad. Sci. USA 108, 16741-16746 (2011).
  13. Topham, D. & Reilly, E. Tissue-resident memory CD8(+) T cells: from phenotype to function. Front. Immunol. 9, 515 (2018).
  14. Muruganandah, V., Sathkumara, H. D., Navarro, S. & Kupz, A. A systematic review: the role of resident memory T cells in infectious diseases and their relevance for vaccine development. Front. Immunol. 9, 1574 (2018).
  15. de Bree, G. et al. Characterization of CD4+ memory T cell responses directed against common respiratory pathogens in peripheral blood and lung. J. Infect. Dis. 195, 1718 (2007).
  16. Piet, B. et al. CD8(+) T cells with an intraepithelial phenotype upregulate cytotoxic function upon influenza infection in human lung. J. Clin. Investig. 121, 2254 (2011).
  17. Turner, D. et al. Lung niches for the generation and maintenance of tissue- resident memory T cells. Mucosal Immunol. 7, 501 (2014).
  18. Pizzolla, A. et al. Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles. J. Clin. Investig. 128, 721 (2018).
  19. Zens, K., Chen, J. & Farber, D. Vaccine-generated lung tissue-resident memory T cells provide heterosubtypic protection to influenza infection. J. Clin. Invest. Insight 1, e85832 (2016).
  20. Sant, S. et al. Single-cell approach to influenza-specific CD8(+) T cell receptor repertoires across different age groups, tissues, and following influenza virus infection. Front. Immunol. 9, 1453 (2018).
  21. Clemens, E., van de Sandt, C., Wong, S., Wakim, L. & Valkenburg, S. Harnessing the power of T cells: the promising hope for a universal influenza vaccine. Vaccines (Basel) 6, E18 (2018).
  22. Cheng, X. et al. Evaluation of the humoral and cellular immune responses eli- cited by the live attenuated and inactivated influenza vaccines and their roles in heterologous protection in ferrets. J. Infect. Dis. 208, 594 (2013).
  23. Jang, Y. et al. Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets. Vaccine 31, 1320 (2013).
  24. Sommer, C., Resch, B. & Simoes, E. Risk factors for severe respiratory syncytial virus lower respiratory tract infection. Open Microbiol. J. 5, 144 (2011).
  25. Falsey, A., Hennessey, P., Formica, M., Cox, C. & Walsh, E. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352, 1749 (2005).
  26. Habibi, JozwikA. et al. Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus. Am. J. Respir. Crit. Care Med. 191, 1040 (2015).
  27. Heidema, J. et al. CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J. Immunol. (Baltim., Md: 1950) 179, 8410 (2007).
  28. Jozwik, A. et al. RSV-specific airway resident memory CD8+ T cells and differ- ential disease severity after experimental human infection. Nat. Commun. 6, 10224 (2015).
  29. Cannon, M., Openshaw, P. & Askonas Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168, 1163 (1988).
  30. Alwan, W., Record, F. & Openshaw, P. CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells. Clin. Exp. Immunol. 88, 527 (1992).
  31. Li, H. et al. Respiratory syncytial virus elicits enriched CD8+ T lymphocyte responses in lung compared with blood in African green monkeys. PLoS ONE 12, e0187642 (2017).
  32. Kinnear, E. et al. Airway T cells protect against RSV infection in the absence of antibody. Mucosal. Immunol. 11, 290 (2018).
  33. Webb, J., Milne, K. & Nelson, B. Location, location, location: CD103 demarcates intraepithelial, prognostically favorable CD8(+) tumor-infiltrating lymphocytes in ovarian cancer. Oncoimmunology 3, e27668 (2014). 152. Komdeur, F. L. et al. CD103+ tumor-infiltrating lymphocytes are tumor-reactive intraepithelial CD8+ T cells associated with prognostic benefit and therapy response in cervical cancer. Oncoimmunology 6, e1338230 (2017). 153. Floc'h, A. et al. αEβ7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosis. J. Exp. Med. 204, 559-570 (2007). 154. Duhen, T. et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat. Commun. 9, 2724 (2018). 155. Molodtsov, A. & Turk, M. Tissue resident CD8 memory T cell responses in cancer and autoimmunity. Front. Immunol. 9, 2810 (2018). 156.
  34. Clarke, J. et al. Single-cell transcriptomic analysis of tissue-resident memory T cells in human lung cancer. J. Exp. Med. https://doi.org/10.1084/jem.20190249 (2019). 157. Park, S. L., Gebhardt, T. & Mackay, L. K. Tissue-resident memory T cells in cancer immunosurveillance. Trends Immunol. 40, 735-747 (2019). 158. Franciszkiewicz, K. et al. CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T- cell effector functions. Cancer Res. 73, 617-628 (2013). 159. Amsen, D., van Gisbergen, K., Hombrink, P. & van Lier, R. Tissue-resident memory T cells at the center of immunity to solid tumors. Nat. Immunol. 19, 538-546 (2018). 160. Malik, B. et al. Resident memory T cells in the skin mediate durable immunity to melanoma. Sci. Immunol. 2, eaam6346 (2017). 161. Galvez-Cancino, F. et al. Vaccination-induced skin-resident memory CD8(+) T cells mediate strong protection against cutaneous melanoma. Oncoimmu- nology 7, e1442163 (2018). 162. Molina, J. R., Yang, P., Cassivi, S. D., Schild, S. E. & Adjei, A. A. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin. Proc. 83, 584-594 (2008). 163. Morales, A., Eidinger, D. & Bruce, A. W. Intracavitary Bacillus Calmette-guerin in the treatment of superficial bladder tumors. J. Urol. 116, 180-182 (1976). 164. · DOI

Cited by

Sorted by citations

Authors
Sasson, S. C., Gordon, C. L., Christo, S. N., Klenerman, P., & Mackay, L. K.
Affiliations
  • University of Oxford (GB)
  • The University of Melbourne (AU)
Corresponding author
  • Klenerman, P.
  • Mackay, L. K.
Venue
Cellular & Molecular Immunology
Published
2020-01-22
Volume
17
Issue
2
Pages
113-122
ISSN
  • 1672-7681 (ISSN-L)
  • 2042-0226
OpenAlex
W3001523894
Cited by
111
References
11
Citations by year
2026: 7 · 2025: 16 · 2024: 28 · 2023: 21 · 2022: 16 · 2021: 15 · 2020: 7 · 2019: 1
FWCI
1.44
Type
journal article
Language
en
Open access
Locations
  • Cellular and Molecular Immunology (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Celgene
  • Sylvia and Charles Viertel Charitable Foundation
  • Wellcome Trust (109965/Z/15/Z)
  • National Institute for Health and Care Research (NF-SI-0515-10005)
  • National Health and Medical Research Council (1160963)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
tissue-resident memory T cells, local immunity, infection immunity, tumor immunology, autoimmune skin disease, psoriasis, alopecia areata, vitiligo, pro-inflammatory response, immunotherapy, T cell biology
MeSH terms
Animals, Autoimmune Diseases, Communicable Diseases, Disease Models, Animal, Graft Rejection, Humans, Immunologic Memory, Neoplasms, CD4-Positive T-Lymphocytes, Autoimmunity, CD8-Positive T-Lymphocytes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review